Product image of Minocin (Minocycline Hydrochloride) supplied by GNH India

Minocin

Active Ingredient:
Minocycline Hydrochloride
Origin:
EU

Minocin (Minocycline Hydrochloride)

Minocycline, the active ingredient in Minocin, is a tetracycline antibiotic presented as an oral tablet for oral use. It is employed to treat bacterial infections such as acne vulgaris, respiratory tract infections, urinary tract infections, and skin and soft‑tissue infections in adult patients.

GNH India supplies Minocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Teofarma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minocin is indicated for bacterial infections affecting several organ systems, primarily targeting Gram‑positive and Gram‑negative organisms.

  • Acne vulgaris: reduces inflammatory lesions and bacterial load on the skin.
  • Respiratory tract infections: eradicates susceptible pathogens causing bronchitis and sinusitis.
  • Urinary tract infections: clears infection of the bladder and urethra.
  • Skin and soft‑tissue infections: treats cellulitis, abscesses and infected wounds.

How It Works

  • Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the addition of aminoacyl‑tRNA to the growing peptide chain. This prevents translation of essential proteins, leading to bacteriostatic activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Adverse reactions to Minocin vary in frequency and severity.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Photosensitivity: increased skin reaction to sunlight.
  • Dizziness: transient vertigo or light‑headedness.

Serious or Rare Side Effects

  • Drug‑induced hepatitis: elevated liver enzymes and possible jaundice.
  • Pseudotumor cerebri: headache with visual disturbances and papilledema.
  • Severe allergic reaction: rash, swelling, and potential anaphylaxis.

Precautions & Warnings

When prescribing Minocin, clinicians should consider several safety measures.

  • Assess renal function: dose adjustment may be required in impairment.
  • Check for hypersensitivity: avoid in patients with known tetracycline allergy.
  • Monitor hepatic enzymes: potential liver toxicity.
  • Avoid in children under 8 and pregnant women: risk of tooth discoloration.
  • Store at ambient temperature: keep in original container, protect from moisture.

Avoid Interactions

Minocin can alter the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce absorption of minocycline.
  • Iron supplements: chelate the drug and lower bioavailability.
  • Warfarin: may enhance anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may reduce efficacy, requiring additional contraception.
  • Retinoids: increased risk of intracranial hypertension.
  • Cyclosporine: may increase nephrotoxicity when used together.

Frequently Asked Questions

Minocin is prescribed for several bacterial infections, including moderate to severe acne vulgaris, respiratory tract infections such as bronchitis and sinusitis, urinary tract infections, and skin or soft‑tissue infections like cellulitis and abscesses. It targets susceptible Gram‑positive and Gram‑negative organisms in these clinical settings.

Minocycline belongs to the tetracycline class and works by binding to the 30S subunit of bacterial ribosomes. This binding blocks the addition of aminoacyl‑tRNA to the growing peptide chain, halting protein synthesis and resulting in a bacteriostatic effect that limits bacterial growth.

The exact dose of Minocin is determined by the prescribing clinician based on the specific infection, severity, patient weight, renal and hepatic function, and any concomitant medications. Dosage regimens are individualized and should follow the prescriber’s instructions and local guidelines.

Safety data for minocycline in pregnancy and lactation are limited. The drug is generally avoided in pregnant women and nursing mothers because it can cross the placenta and enter breast milk, potentially causing fetal tooth discoloration or other developmental effects. Clinicians should weigh risks and benefits before prescribing.

To order Minocin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Both Minocin (minocycline) and doxycycline are tetracycline antibiotics, but minocycline has higher lipid solubility, allowing better tissue penetration and a longer half‑life, which may permit once‑daily dosing. Doxycycline is often preferred for its lower risk of vestibular side effects, while minocycline may be chosen for more severe acne or infections requiring deeper tissue levels.

Minocin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain stability throughout its shelf life.

Minocin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids, iron or calcium supplements within two hours, as these can reduce absorption. The exact schedule is set by the prescribing healthcare professional.

Serious risks include drug‑induced hepatitis, which may present with jaundice and elevated liver enzymes, and pseudotumor cerebri, a condition characterized by severe headache, visual changes and papilledema. Anaphylactic reactions, though rare, can also occur and require immediate medical attention.

Minocin should not be used by individuals with a known hypersensitivity to minocycline or other tetracyclines. It is also contraindicated in children under eight years of age and in pregnant or lactating women due to the risk of permanent tooth discoloration and other developmental effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.